Showing results (581-590 of 657) with videos related to
Sort By:
Pageof 66
Arthritis Research & Therapy|September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohortRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.Journal of the Peripheral Nervous System : JPNS|September 22, 2021
Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control studySonja E Leonhard, Cheng Yin Tan, Annemiek A van der Eijk, et al.BMC Health Services Research|December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal studyEmanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.Journal of Biomedical Informatics|October 20, 2010
The Biomedical Resource Ontology (BRO) to enable resource discovery in clinical and translational researchJessica D Tenenbaum, Patricia L Whetzel, Kent Anderson, et al.Cancer Discovery|September 15, 2022
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk NeuroblastomaKristopher R Bosse, Anna Maria Giudice, Maria V Lane, et al.BMC Rheumatology|September 11, 2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal studyDelia Colombo, Micol Frassi, Giusy Pagano Mariano, et al.Women'S Health Reports (New Rochelle, N.Y.)|March 9, 2022
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A Post Hoc Gender AnalysisDelia Colombo, Micol Frassi, Giuseppa Pagano Mariano, et al.Autoimmunity Reviews|July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registryFabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.Medicina|October 25, 2013
[Guidelines for diagnosis, monitoring and treatment of Fabry disease], Pablo Neumann, Norberto Antongiovanni, et al.Nucleic Acids Research|December 1, 2016
The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across speciesChristopher J Mungall, Julie A McMurry, Sebastian Köhler, et al.Pageof 66